Literature DB >> 10461065

Neoangiogenesis and relationship to nuclear p53 accumulation and vascular endothelial growth factor expression in advanced gastric carcinoma.

H Saito1, S Tujitani, M Ikeguchi, M Maeta, N Kaibara.   

Abstract

Recent studies have shown that tumor suppressor genes, particularly p53, may play a crucial regulatory role in the control of angiogenesis. Accordingly, we analyzed the correlation between p53 accumulation and the expression of vascular endothelial growth factor (VEGF) and microvessel counts in a series of human gastric adenocarcinomas by immunohistochemical staining. p53 expression was absent in 35 cases (29.7%), weak in 34 cases (28.8%), moderate in 35 cases (29.7%), and strong in 14 cases (11.8%). The prognosis of patients with both absent and weak expression of p53 was significantly better than that of patients with both moderate and strong expression of p53. VEGF expression was significantly associated with increased p53 expression. Moreover, increasing expression of p53 significantly correlated with an increase in microvessel counts. Nuclear p53 accumulation may correlate with tumor angiogenesis through VEGF upregulation in gastric carcinomas.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10461065     DOI: 10.1159/000012025

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  8 in total

1.  Prognostic significance of vascular endothelial growth factor expression in gastric carcinoma: a meta-analysis.

Authors:  Jing Chen; Tao Li; Yuanyuan Wu; Lijun He; Li Zhang; Tieliu Shi; Zhengfang Yi; Mingyao Liu; Xiufeng Pang
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-15       Impact factor: 4.553

Review 2.  Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches.

Authors:  Ronnie Tung-Ping Poon; Sheung-Tat Fan; John Wong
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

3.  Significance of vascular endothelial growth factor expression and its correlation with inducible nitric oxide synthase in gastric cancer.

Authors:  Zhen-Ya Song; Shu-Qun Wen; Jia-Ping Peng; Xuan Huang; Ke-Da Qian
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

4.  Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival, and tumor surgery.

Authors:  Anastasios J Karayiannakis; Konstantinos N Syrigos; Alexandros Polychronidis; Andrew Zbar; Gregory Kouraklis; Constantinos Simopoulos; Gabriel Karatzas
Journal:  Ann Surg       Date:  2002-07       Impact factor: 12.969

5.  Neuroendocrine differentiation in gastric adenocarcinomas; correlation with tumor stage and expression of VEGF and p53.

Authors:  Funda Eren; Ciğdem Celikel; Bahadir Güllüoğlu
Journal:  Pathol Oncol Res       Date:  2004-03-18       Impact factor: 3.201

6.  Relationship between VEGF and p53 expression and tumor cell proliferation in human gastrointestinal carcinomas.

Authors:  Elvira Montero; Carmen Abreu; Paola Tonino
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-17       Impact factor: 4.553

7.  Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features.

Authors:  Chang Wei Feng; Li Dong Wang; Lian Hua Jiao; Bin Liu; Shu Zheng; Xin Ji Xie
Journal:  BMC Cancer       Date:  2002-04-29       Impact factor: 4.430

8.  The role of vascular endothelial growth factor (VEGF) and p53 status for angiogenesis in gastric cancer.

Authors:  Young Eun Joo; Young Hae Sohn; So Young Joo; Wan Sik Lee; Sang Woon Min; Chang Hwan Park; Jong Sun Rew; Sung Kyu Choi; Chang Soo Park; Young Jin Kim; Sei Jong Kim
Journal:  Korean J Intern Med       Date:  2002-12       Impact factor: 2.884

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.